PlainRecalls
FDA Drug Critical Class I Terminated

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reported: October 9, 2024 Initiated: September 19, 2024 #D-0005-2025

Product Description

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for Recall

Presence of Particulate Matter: Presence of glass particle.

Details

Recalling Firm
Gilead Sciences, Inc.
Units Affected
105,000 vials
Distribution
Nationwide in the U.S.A.
Location
Foster City, CA

Frequently Asked Questions

What product was recalled?
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2. Recalled by Gilead Sciences, Inc.. Units affected: 105,000 vials.
Why was this product recalled?
Presence of Particulate Matter: Presence of glass particle.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 9, 2024. Severity: Critical. Recall number: D-0005-2025.